EP

13 Years in the Making: The Philips Judgment and its Impact on SEP Litigation in India

Introduction The Delhi High Court (DHC)’s recent decision in Koninklijke Philips Electronics N.V. vs. Maj (Retd) Sukesh Behl & Anr. [1] 1is another firm reinforcement of India’s growing reputation as a key jurisdiction for Standard Essential Patent (SEP) enforcement. While India has consistently handled SEP litigation with legal sophistication and commercial pragmatism, this ruling reinforces […]
Read more

Medical Use Claims in India, US, and EP

Introduction Medical use claims constitute an important aspect of the pharmaceutical industry. Such claims comprise the use of known substances for the treatment of diseases or any other medical procedure. These types of claims may comprise the ‘first use’ or ‘subsequent use’ of the existing product or process. However, the Indian Patent Act does not […]
Read more

Subscribe To Our Newsletter

Reach us at knk@kankrishme.com

X